Launching a MedTech product without a prospect database (2026)

France has 593 practicing vascular surgeons (medical demographics, 2022), or fewer than one per 100,000 people. That’s fewer than a single engineering school’s graduating class. For a manufacturer launching a product line that touches this specialty, that number changes everything: the target isn’t a market to conquer; it’s a closed list of people to identify by name.

So launching a MedTech product in a specialty you don’t already cover isn’t a volume campaign; it’s the exhaustive identification of a small population. The problem isn’t sending lots of messages; it’s knowing who to send them to, when your CRM, purchased databases, and LinkedIn don’t recognize the specialty as such.

This article explains why an adjacent specialty has no usable prospect database, where the information that describes it actually lives, why buying a list is the worst way to start, and how to build the target from signals rather than from a job title.

Why doesn’t a new surgical specialty have a prospect database?

A surgical specialty that’s missing from your sales history has no prospect database because it doesn’t map to a LinkedIn job title, a line in your CRM, or a segment in general-purpose B2B databases. A surgeon describes themselves as a “surgeon” or a “hospital practitioner,” rarely as a “vascular surgeon” in a structured, searchable field. The specialty exists in the real world; it’s invisible to tools that filter by title.

The trap is that a vertical launch gives the illusion of a starting point. The team already knows orthopedic surgeons, for example, because that’s the core business. But a product line that also touches vascular surgeons runs into a target with no relationship, no list, and no history. Sales maturity in one specialty doesn’t carry over to the specialty next door.

The result: you launch a product knowing exactly what it solves, without knowing who to offer it to. That’s an uncomfortable asymmetry for a product manager, because a better pitch won’t fix it. It gets fixed upstream, through target-building work that no one on the team has ever had to do for this specialty.

Where does information about a specialty missing from your CRM actually live?

The information that describes a surgical specialty lives in public and academic registries, not in commercial databases. The RPPS (France’s national registry of healthcare professionals) lists every healthcare professional with their official specialty. Medical societies keep lists of their members. Scientific publications (PubMed, ResearchGate) show who works on what. Conference programs name the speakers. None of these sources is in Apollo or Sales Navigator.

These are exactly the sources that let you identify a specialty by what practitioners do, not by what they claim. A surgeon who publishes on arterial disease, speaks at a vascular surgery conference, and belongs to a medical society in the discipline is a vascular surgeon, whatever title appears on their LinkedIn profile.

Cross-referencing these registries rebuilds what a purchased database will never contain: a map of the specialty based on actual activity. It’s the underlying logic of the guide to MedTech prospecting with buying signals, applied here not to date a buying window but to bring into view a target that standard tools can’t see.

Why is buying a ready-made list the worst way to start?

Buying a ready-made list is the worst way to start because a healthcare contact database goes stale fast and no general-purpose vendor segments by surgical subspecialty. You pay for a file that’s already partly wrong on the day it’s delivered, and poorly targeted by design: it sorts physicians into broad categories, never by the specific discipline you care about.

The real cost isn’t the price of the file; it’s the time wasted prospecting the wrong people and the damage to your brand at the first off-target message. An orthopedic surgeon contacted about a vascular product mostly remembers that the manufacturer doesn’t know who it’s talking to. In a population of a few hundred people who know each other and cross paths at conferences, that mistake gets around.

That’s the argument laid out in detail in why buying a B2B healthcare database means buying an asset that’s already dead: a list’s value doesn’t lie in its volume but in its freshness and targeting precision, and a purchased file guarantees neither.

How do you build the target from signals rather than a job title?

You build the target from activity signals rather than a job title: scrape broadly across public sources, then disqualify tightly until you have a clean list for the specialty you’re after. The method reverses the usual order. Instead of searching for “vascular surgeon” directly in a database, you gather every plausible practitioner, then exclude anyone outside the discipline, based on publications, medical societies, and procedures.

This exclusion-based approach produces a more accurate list than a keyword search, because it captures practitioners who practice the specialty without advertising it. It rests on the same principle as reverse prospecting, which detects the need before pushing the message: you start from what people do, not what they claim.

For a launch, the right first deliverable isn’t the complete national list; it’s a dense sample for one region or segment, precise enough to serve as proof. If you’re launching into an unfamiliar vertical, the most useful conversation is to scope together the sources that describe your specialty and the disqualification rule that will produce a clean list. That’s exactly what Agify runs: cross-referencing public healthcare registries, applying specialty-based exclusion logic, and delivering a qualified target instead of a raw file.

What does launching into an unfamiliar vertical look like in practice?

In practice, launching into an unfamiliar vertical starts with a pre-sale sample, not a campaign. An orthopedic medical device manufacturer, launching a product line that touched an adjacent specialty it didn’t cover, framed the problem exactly this way: its sales reps knew orthopedic surgeons, but the surgeons in the adjacent specialty were complete strangers, with no list and no prior relationship.

The starting point wasn’t buying a file but producing a dense target extract for a single French region, cross-referencing public and academic sources, including PubMed and ResearchGate to identify the discipline’s key opinion leaders. That sample serves an internal purpose first: it proves the invisible specialty can become a named, actionable list before any larger-scale commitment.

The product manager summed up the offering in a phrase that captures what he was looking for: “an enhanced search engine for MedTech.” Not one more database, but a way to bring into view a target his tools couldn’t build. This case is still in the scoping phase: it illustrates the method for getting started on a specialty with no database, not a campaign result. The proof of value comes from how accurate the list is, before a single sequence goes out.

Frequently asked questions

Why isn’t LinkedIn enough to target a surgical specialty?

LinkedIn sorts practitioners by self-reported title, not by actual specialty. A surgeon often shows up there as a “surgeon” or “hospital practitioner,” with no subspecialty filled in a searchable field. Sales Navigator inherits that limit: it identifies who exists, not who actually practices the discipline you’re targeting. For a narrow specialty, filtering by title misses part of the target and pulls in the wrong people.

How many practitioners does a surgical specialty have in France?

It varies a lot by discipline, but many surgical specialties number in the hundreds, not the thousands. As a benchmark, France had 593 vascular surgeons in 2022. A population that size can be identified by name and exhaustively, which changes the strategy: the goal isn’t to reach volume but to leave no one out.

Do you need a complete national list before launching?

No. For a launch, a dense sample for one region or segment is more useful than an incomplete national list. It serves as internal proof of value, lets you test your sales approach on an accurate target, and then scales up. Starting small and precise beats starting broad and fuzzy.

How do you identify a specialty’s key opinion leaders?

Key opinion leaders stand out through their public activity: scientific publications (PubMed, ResearchGate), conference talks, and leadership roles in medical societies. These sources show who is an authority on a topic, information that commercial databases lack. For a launch, these practitioners are often the first to contact, because their adoption influences the rest of the discipline.

Conclusion

Launching a MedTech product in a specialty you don’t cover isn’t a volume problem; it’s an identification problem. Three takeaways: a surgical specialty is a finite, nameable population, not a market, and you identify it one person at a time; that information lives in public registries, medical societies, and publications, never in purchased databases; and the right method is to scrape broadly and then disqualify tightly, to get an accurate list rather than a bulky file.

What’s left is figuring out which sources describe your specific specialty. Let’s talk for 30 minutes: together we’ll identify the public registries that make your target visible, and the disqualification rule that turns it into a list ready to activate.

---

Agify deploys autonomous AI prospecting agents inside B2B sales teams, with a specialization in the French MedTech market and its public healthcare and procurement sources.